More intelligence articles

Genomic medicine: collaborating for diverse data

How international collaboration could help encourage more diverse data for genomic research and ultimately improve global health

Vive la différence: as Cannes celebrates life-changing creative, how did pharma do?

As brands leverage the power of creativity to make a meaningful difference to lives and their businesses, pharma is finally making a splash on the French Riviera

Resisting the resistance

How genomics can help us win the fight against AMR

Creating truly effective communications – the impact of high speed, high octane messaging

Navigating the busy omnichannel communication lanes to make the best of digital

Choosing capabilities

Why tomorrow’s business model must be more capable than today’s model

AI – the next paradigm shift in healthcare

How to create healthy ecosystems for positive progress

Driving conscious inclusion within organisations

Cultivating inclusive behaviours within the workforce takes ongoing and deliberate effort

Using knowledge graphs to discover powerful new insights

Looking at how multidimensional knowledge graphs work and their potential within the life sciences industry

Powering creativity to work in harmony with science and data

Companies need creativity at the heart of their output – with social media and new channels presenting new horizons and challenges

Cardiovascular disease: the impact of COVID-19 on patient outcomes

JoAnne Foody talks to PME about the role of statins in helping to prevent cardiovascular disease

To support patient-centricity in clinical trials, look to rare disease communities

How patients are seeking new treatment options that will advance the care of their communities

Can the patient pathway provide a route to success?

Why pharma companies need to identify barriers and co-create solutions along the patient pathway to ensure their new products reach the patients who need them

Parkinson’s disease: past, present and future

Examining the history and complexities of Parkinson’s disease – one of the most prevalent neurodegenerative disorders that affects over 10 million people worldwide

The 17th World Congress on Controversies in Neurology

This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women

Tuberculosis – why it remains a major global public health challenge

Innovative collaboration is required to address the major public health challenges around TB and expedite drug development